Will the CDC declare the Taco Bell-associated Cyclospora outbreak over by August 15, 2026?

This market resolves to Yes if the U.S. Centers for Disease Control and Prevention (CDC) issues a formal public health advisory related to a multistate cyclosporiasis outbreak linked to lettuce by the end of July 31, 2026. The advisory must specifically mention lettuce as a confirmed vehicle of transmission. The market resolves to No if no such advisory is issued by that date.

This market resolves to Yes if the World Health Organization (WHO) publicly announces a new global initiative specifically aimed at reducing dementia risk (e.g., through actionable guidelines, public campaigns, or research funding) by October 1, 2026. This initiative must go beyond existing dementia-related recommendations or programs and involve a formal new announcement from the WHO.

This market resolves to Yes if the WHO's Europe Regional Office publicly announces the finalization and publication of its new digital health strategy by August 31, 2026. The resolution will be based on official and verifiable announcements from the WHO Regional Office for Europe or relevant trusted media sources. If no announcement is made by this date, the market resolves to No.

This market resolves to Yes if the World Health Organization (WHO) publicly releases its global digital health strategy by July 31, 2026. Any official statement, publication, or press release confirming the release will constitute resolution. A lack of announcement or confirmation by this date resolves the market to No.

This market resolves to Yes if the U.S. Food and Drug Administration (FDA) announces formal approval of the first regenerative injection therapy for osteo-arthritis, as described in recent research news, by August 31, 2026. Any official FDA announcement, press release, or public database update confirming approval will determine the outcome. If no such approval is granted by the close date, the market resolves to No.

Will Linear Health Sciences' Orchid SRV be launched in Japan by July 22, 2026?

This market resolves to Yes if Linear Health Sciences and NIPRO CORPORATION launch the Orchid Safety Release Valve (SRV) in the Japanese market on or before July 22, 2026, as per their announcement. The launch must involve public confirmation of product availability in Japan or sales starting by the specified date, confirmed through media reports or an official press release.